Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    INFLAMMATORY BOWEL DISEASE 19
Show Display Options
Rank Status Study
1 Active, not recruiting Efficacy, Safety and Pharmacokinetics of BI 655066 in Patients With Active, Moderate-to-severe Crohn's Disease.
Condition: Crohn Disease
Interventions: Drug: BI 655066 period 2;   Drug: BI 655066 (high dose);   Drug: BI 655066 (low dose);   Drug: BI 655066 one dose;   Drug: placebo dose

Indicates status has not been verified in more than two years